Evaluation of interleukin 12 and CD56+ lymphocyte cells in pediatric hematopoietic stem cell transplantation for early diagnosis of acute graft versus host disease
- 1 November 2016
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 39, 25-29
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effectsBlood, 2010
- Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificityBlood, 2009
- The biology and treatment of chronic lymphocytic leukemiaAnnals of Oncology, 2006
- Hematopoietic Stem-Cell TransplantationNew England Journal of Medicine, 2006
- Pathophysiology of Graft-Versus-Host DiseaseSeminars in Hematology, 2006
- Non-HLA immunogenetics in hematopoietic stem cell transplantationCurrent Opinion in Immunology, 2005
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- The role of donor T cells for target organ injuries in acute and chronic graft‐versus‐host diseaseImmunology, 2001
- EVIDENCE THAT LARGE GRANULAR LYMPHOCYTES OF DONOR ORIGIN MEDIATE ACUTE GRAFT-VERSUS-HOST DISEASETransplantation, 1989
- PREVENTION OF MURINE GRAFT-VERSUS-HOST DISEASE BY INDUCING AND ELIMINATING ASGM1+ CELLS OF DONOR ORIGINTransplantation, 1988